SMi is proud to announce the inaugural Prefilled Syringes San Francisco event taking place in September 2020.
The global pre-filled syringes market was valued at $4.9 billion in 2018 and with the rapid growth of the industry, is expected to exceed $9.7 billion by 2025. With that in mind, this event will bring together specialists within the industry to provide an exclusive insight into the sphere of regulation, new digital technology trends, human factors studies and innovative design and delivery systems within the prefilled syringes industry.
As part of SMi's leading Injectable conference series, we will assess digital health and connected devices, biologics, biosimilars and biocompatibility for drug/device combination products, platform and device selection, regulatory insights and hear from the West Coast's biotech innovators.
This two-day agenda offers you peer-to-peer networking with Global Product Managers, Device Testing Managers, Senior Device Engineers, Heads of Device Development, Heads of Formulation and Drug Process Development, and many more.
We look forward to welcoming you to the conference in September.
BENEFITS OF ATTENDING:
- EXPLORE the latest industry case studies in platform approaches and connected devices
- GAIN insights from leading industry and regulatory experts on the pre-filled syringes environment
- HEAR from local biotechs of San Francisco and the West Coast to learn about new innovations in the pre-filled syringes space
- ENGAGE in the key challenges and topics of the field in two interactive half-day workshops